Search Results 1221-1230 of 13318 for monoclonal antibody
Has had a prior anti-cancer monoclonal antibody (mAb) <= 4 weeks prior to ... Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).
Relapsed, progressive and/or refractory disease following treatment with an anti-CD20 monoclonal antibody (e.g., rituximab) potentially in combination with ...
Adults who are just initiating monoclonal antibody therapy with pembrolizumab or nivolumab for melanoma or non-small cell lung cancer. Exclusion Criteria ...
A Study To Evaluate The Efficacy And Safety Of Rozanolixizumab In Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...
We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the ...
* Discontinued use of prior immune checkpoint therapy due to immune related adverse events; received prior treatment with an anti-TIGIT monoclonal antibody.
Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.
Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...
Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · Multiple myeloma · Myxofibrosarcoma ...
Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.